GET THE APP

Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

+44 1223 790975

Vukoman Jokanovic

Vukoman Jokanovic

Institute of Nuclear Sciences “Vinča”, Belgrade, Serbia

Biography
Between 1988 and 1992 he was declared UNIDO's expert for special alumina and ceramic fibers. He participates and coordinates projects of excellence within Sixth Framework Programme, FP6 in the field of regenerative medicine and implantology and. Eureka Cell. He is the author and coauthor of about 120 papers published in international journals, most of which with high impact factors, and of 45 papers published in the leading national journals. He is author of unique monographes, titled: Nanomedecine, the greatest challenge of 21. century, (written on about 830 pages), How died and lived our cells (539 pages) and Instrumental methods a key for understanding nanotechnology and nanomedicine (847 pages), dedicated to key relationships between nanotechnology and medicine and biology. Investigations in the field of regenerative medicine, concentrated on the scaffolds of porous ceramic and composite structures, include investigations of a complex structure geometric design through several hierarchical levels. His recent field of activity is also encapsulation of drugs, control rate of drug release, specificity of activity for various kinds of bacteria, application of drug when there is inflammation of the tissues around the bone implants, specific way of drug administration independent of the type of tissue being treated and drug's direct contact only with the treated, the possibility of drug universal application and methodology, isolation and packing into thin-layer structures of various polymers deposited on the surface of the scaffold thin walls with stem cells of various origins (from various sources), encapsulation of antigens and growth factors, investigation of specific interaction between scaffolds and live cells, etc
Research Interest

Encapsulation of drugs, control rate of drug release, specificity of activity for various kinds of bacteria, application of drug when there is inflammation of the tissues around the bone implants, specific way of drug administration independent of the type of tissue being treated and drug's direct contact only with the treated, the possibility of drug universal application and methodology, isolation and packing into thin-layer structures of various polymers deposited on the surface of the scaffold thin walls with stem cells of various origins (from various sources), encapsulation of antigens and growth factors, investigation of specific interaction between scaffolds and live cells

Relevant Topics

Top